Recommended Protocol for Post-Weight-Loss Skin Tightening Dosage: 2 mg daily subcutaneous injection Cycle length: 10 to 12 weeks Rest period: 4 to 6 weeks between cycles Injection sites: Rotate between abdomen, upper arms, and thighs Optional addition: Topical GHK-Cu serum (0.5 to 1%) applied to problem areas Cycles per year: 2 to 3 Subcutaneous injection is the preferred route for skin applications because it provides near 100% bioavailability and allows for easy self-administration using 29 to 31 gauge insulin syringes at a 45 to 90 degree angle
For a full comparison, read Lyvs guide to Wegovy pill vs injection in the UK
Still, last month, Novo Nordisk told investors that compounded versions of obesity drugs were officially eating into its sales of Wegovy
& Zou, J
Prescribing Information (Wegovy, semaglutide) GoodRx: Liraglutide Costs NIH: Efficacy of Liraglutide 3.0 mg in Overweight Individuals NIH: Early response as a predictor of longer-term outcomes VerywellHealth: Differences in Saxenda and Wegovy NIH: Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight NEJM: Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes NIH: GLP-1 Receptor Agonists and the Thyroid Disclaimer This article is intended for educational and informational purposes only and should not be interpreted as medical advice, diagnosis, or treatment
A Statistically Significant Risk